Boehringer 1218

Enroll Now

Type of Study:

Type 2 diabetes patients who are between 10 to 17 years

Title of Study:

This study will assess how well empagliflozin and linagliptin work in children and adolescents.

Short Title:

DINAMO

Study Length: 52 weeks

Target Age/Sex: 10 – 17 years, Male and Female

Benefits:

Participants will receive at no cost: study product, study materials and study-specific procedures

Link: ClinicalTrials.gov